FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2065952992> ?p ?o ?g. }

• W2065952992 endingPage "393" @default.
• W2065952992 startingPage "392" @default.
• W2065952992 abstract "HomeHypertensionVol. 44, No. 4Gender Dependency in the Pathogenesis of Cardiac Hypertrophy Free AccessEditorialPDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessEditorialPDF/EPUBGender Dependency in the Pathogenesis of Cardiac HypertrophyEffect of Norepinephrine on Transforming Growth Factor-β Release in Female Heart Ian M.C. Dixon and Vanja Drobic Ian M.C. DixonIan M.C. Dixon From the Institute of Cardiovascular Sciences, St. Boniface General Hospital Research Centre and Department of Physiology, University of Manitoba, Winnipeg, Canada. Search for more papers by this author and Vanja DrobicVanja Drobic From the Institute of Cardiovascular Sciences, St. Boniface General Hospital Research Centre and Department of Physiology, University of Manitoba, Winnipeg, Canada. Search for more papers by this author Originally published23 Aug 2004https://doi.org/10.1161/01.HYP.0000141484.53649.6fHypertension. 2004;44:392–393Other version(s) of this articleYou are viewing the most recent version of this article. Previous versions: August 23, 2004: Previous Version 1 Representing the most numerous nonmyocytes in the myocardium, adult cardiac fibroblasts (and myofibroblasts) function to synthesize fibrillar collagens and thus maintain the integrity of the cardiac extracellular matrix (matrix). Matrix remodeling is manifest as interstitial fibrosis of the remnant heart or the progressive evolution of the structure of the infarct scar in the etiology of post-myocardial infarction heart failure.1 In normal heart tissue, matrix protein secretion and deposition is carried out exclusively by cardiac fibroblasts with relatively low turnover of proteins, whereas contractile and hypersynthetic myofibroblasts are the relevant phenotypic variant in wound healing2 or in hypertrophied and failing hearts.3,4 Much of the current literature that addresses cardiac fibroblast or myofibroblast function deals with the effects of a limited number of profibrotic factors and infrequently addresses the interplay of these stimuli. Whereas interstitial fibrosis is a component of cardiac hypertrophy and contributes to the development of heart failure and norepinephrine stimulation of nonmyocytes is linked to the activation of collagen genes, the precise mechanisms of cardiac myofibroblast activation by this ligand are not well understood.Recently, a direct relation between increased sympathetic activity and hypertensive left ventricular hypertrophy was demonstrated in a small human cohort (notably, ≈35% of these patients were female).5 Indeed, β-blockers are again among the agents of choice in the clinician’s armament for treatment of cardiac hypertrophy and heart failure.6 In contrast, α-blockers have attracted relatively little attention in the clinical setting. Despite the association between plasma norepinephrine and incidence of maladaptive cardiac hypertrophy, the role of norepinephrine as a synergistic partner with common trophic cytokines, such as members of the transforming growth factor (TGF)-β superfamily, in the pathogenesis of cardiac hypertrophy heart is undefined. Precisely how myofibroblasts integrate norepinephrine and TGF-β (TGF-β1, TGF-β2, and TGF-β3) signals in cardiac hypertrophy and failure is unclear at the level of ligand release. In contrast, it is well known that suppression of angiotensin results in improved outcomes in animal models and patients with maladaptive cardiac hypertrophy and failure secondary to myocardial infarction,7–9 and this is in part related to a reduction of cytokine expression. TGF-β1 is a known stimulus for cardiac myocyte growth as well as for fibrillar collagen secretion by cardiac fibroblasts and myofibroblasts.10Despite the number of clinical and basic science reports in recent years that have dealt with aspects of heart failure, female patient participation in heart failure trials is usually a fraction of that of their male counterparts.5 Support for the argument of gender differences in profile (including age of onset and comorbidities) and management of congestive heart failure exists,5,11 justifying further investigation of gender-dependency in the pathogenesis of cardiac hypertrophy and failure. There is little data that deals specifically with development of cardiac hypertrophy in female animal models. Whether the male myocardium differs from the female in release or effects of TGF-β in the diseased heart remains an open question. Data presented by Briest et al in this issue of Hypertension12 supports the induction of TGF-β1 in female rat heart subjected to norepinephrine infusion. The current study also includes novel data about TGF-β1, TGF-β2, and TGF-β3 release in female hearts and how this event is linked to functional changes in cardiac fibroblasts.Cardiac HypertrophyIn response to one of a number of pathological stimuli (eg, myocardial infarction), the overloaded heart adapts with increased muscle mass (cardiac hypertrophy), usually preceding the occurrence of congestive heart failure, a major cause of death in the North American population. Severe hypertrophy is associated with increased myocyte size and decreased intrinsic cardiac performance.The development of fibrosis in congestive heart failure is a complex process and may involve input from multiple factors.13 It is becoming clear that myofibroblast behavior may also potentiate wound healing and eventual cardiac fibrosis. TGF-β1 is widely studied as a stimulus for fibroblast and myofibroblast function, that is, extracellular matrix deposition, in the setting of cardiac dysfunction.14 TGF-β1 is known to stimulate focal adhesion supermaturation in myofibroblasts,15 which is associated with reduced turnover and decreased cell motility.16 Thus, a clear understanding of control of TGF-β release in heart is of considerable importance to understanding the pathogenesis of hypertrophy.Biology of TGF-β in the Heart and the Putative Role of Norepinephrine in Control of ExpressionWith respect to myofibroblast function, TGF-β1 mediates cell growth and differentiation, tissue wound repair, and extracellular matrix production,17 including regulation of fibrillar collagens, and is expressed in the normal and hypertrophied myocardium. In primary fibroblasts, TGF-β1 is likely to exert effects that impair motility15 and reduce overall proliferation.18 TGF-β1 ligand signaling from cell-surface receptors to the nucleus is transduced by Smads and their DNA-binding partners.19 TGF-β1 receptor type I and II are Ser/Thr kinase class proteins and signal through receptor-regulated Smads (R-Smad 2 or 3) by specific recognition and phosphorylation steps.20 Smad access to Ser/Thr kinase receptors is regulated by Smad anchor for receptor activation (SARA) proteins that bind unphosphorylated R-Smads.21 Activated R-Smads dissociate from SARA and complex with common Smad 4 as heteroligomers (dimers and trimers)22 that translocate to the nucleus20 where binding to a DNA-binding protein occurs.23 R-Smad activation has been linked to activation of collagen genes.24,25Although crosstalk between angiotensin and TGF-β1 ligands has been addressed,26 very little work has been done to examine the role of putative interplay between norepinephrine and TGF-β in heart failure.27 The work by Briest et al12 provides support for this concept in adult myocardium.In this issue, it is demonstrated that ratios of TGF-β1/β2/β3 mRNAs are differentially expressed in male versus female rat heart either in basal conditions or with norepinephrine treatment in both nonmyocyte and myocyte fractions of the left ventricle. Defining the distinguishing mechanisms between female versus male cardiac hypertrophy and heart failure and outlining their similarities are of paramount importance. We suggest that the benefits gained by the addition of an increased number of basic science articles using experimental models of cardiac hypertrophy and failure that focus attention on female/male comparisons may be profound. Thus, the current article12 begins to add to basic research data that will add to information gained from clinical trials that include significant numbers of women in their test groups.The opinions expressed in this editorial are not necessarily those of the editors or of the American Heart Association.V.D. is supported by a studentship from the St. Boniface General Hospital Research Foundation. I.M.C.D. holds the Myles Robinson Heart Fund Scholarship at the University of Manitoba.FootnotesCorrespondence to Ian M.C. Dixon, PhD, Institute of Cardiovascular Sciences, St. Boniface General Hospital Research Centre, 351 Tache Ave, Winnipeg, Manitoba, Canada R2H 2A6. E-mail [email protected] References 1 Weber KT. Fibrosis, a common pathway to organ failure: angiotensin II and tissue repair. Semin Nephrol. 1997; 17: 467–491.MedlineGoogle Scholar2 Gabbiani G. The myofibroblast in wound healing and fibrocontractive diseases. J Pathol. 2003; 200: 500–503.CrossrefMedlineGoogle Scholar3 Peterson DJ, Ju H, Hao J, Panagia M, Chapman DC, Dixon IM. Expression of Gi-2 alpha and Gs alpha in myofibroblasts localized to the infarct scar in heart failure due to myocardial infarction. Cardiovasc Res. 1999; 41: 575–585.CrossrefMedlineGoogle Scholar4 Frangogiannis NG, Smith CW, Entman ML. The inflammatory response in myocardial infarction. Cardiovasc Res. 2002; 53: 31–47.CrossrefMedlineGoogle Scholar5 Schlaich MP, Kaye DM, Lambert E, Sommerville M, Socratous F, Esler MD. Relation between cardiac sympathetic activity and hypertensive left ventricular hypertrophy. Circulation. 2003; 108: 560–565.LinkGoogle Scholar6 Ahmed A. Myocardial beta-1 adrenoceptor down-regulation in aging and heart failure: implications for beta-blocker use in older adults with heart failure. Eur J Heart Fail. 2003; 5: 709–715.CrossrefMedlineGoogle Scholar7 Ju H, Zhao S, Davinder SJ, Dixon IM. Effect of AT1 receptor blockade on cardiac collagen remodeling after myocardial infarction. Cardiovasc Res. 1997; 35: 223–232.CrossrefMedlineGoogle Scholar8 Pfeffer JM, Pfeffer MA, Braunwald E. Influence of chronic captopril therapy on the infarcted left ventricle of the rat. Circ Res. 1985; 57: 84–95.CrossrefMedlineGoogle Scholar9 Jugdutt BI. Effect of captopril and enalapril on left ventricular geometry, function and collagen during healing after anterior and inferior myocardial infarction in a dog model. J Am Coll Cardiol. 1995; 25: 1718–1725.CrossrefMedlineGoogle Scholar10 Butt RP, Laurent GJ, Bishop JE. Collagen production and replication by cardiac fibroblasts is enhanced in response to diverse classes of growth factors. Eur J Cell Biol. 1995; 68: 330–335.MedlineGoogle Scholar11 Silber DH. Heart failure in women. Curr Womens Health Rep. 2003; 3: 104–109.MedlineGoogle Scholar12 Briest W, Homagk L, Rabler B, Zeigelhoffer-Mihalovicova B, Meier H, Tannapfel A, Leiblein S, Saalbach A, Deten A, Zimmer HG. Norepinephrine-induced changes in cardiac TGF-b isoform expression pattern of female and male rats. Hypertension. 2004; 44: 410–418.LinkGoogle Scholar13 Hunter JJ, Chien KR. Signaling pathways for cardiac hypertrophy and failure. N Engl J Med. 1999; 341: 1276–1283.CrossrefMedlineGoogle Scholar14 Deten A, Holzl A, Leicht M, Barth W, Zimmer HG. Changes in extracellular matrix and in transforming growth factor beta isoforms after coronary artery ligation in rats. J Mol Cell Cardiol. 2001; 33: 1191–1207.CrossrefMedlineGoogle Scholar15 Dugina V, Fontao L, Chaponnier C, Vasiliev J, Gabbiani G. Focal adhesion features during myofibroblastic differentiation are controlled by intracellular and extracellular factors. J Cell Sci. 2001; 114: 3285–3296.CrossrefMedlineGoogle Scholar16 Horwitz AR, Parsons JT. Cell migration–movin’ on. Science. 1999; 286: 1102–1103.CrossrefMedlineGoogle Scholar17 Brand T, Schneider MD. Transforming growth factor-beta signal transduction. Circ Res. 1996; 78: 173–179.CrossrefMedlineGoogle Scholar18 Petrov VV, Fagard RH, Lijnen PJ. Transforming growth factor-beta(1) induces angiotensin-converting enzyme synthesis in rat cardiac fibroblasts during their differentiation to myofibroblasts. J Renin Angiotensin Aldosterone Syst. 2000; 1: 342–352.CrossrefMedlineGoogle Scholar19 Wrana JL. Regulation of Smad activity. Cell. 2000; 100: 189–192.CrossrefMedlineGoogle Scholar20 Macias Silva M, Abdollah S, Hoodless PA, Pirone R, Attisano L, Wrana JL. MADR2 is a substrate of the TGFbeta receptor and its phosphorylation is required for nuclear accumulation and signaling. Cell. 1996; 87: 1215–1224.CrossrefMedlineGoogle Scholar21 Tsukazaki T, Chiang TA, Davison AF, Attisano L, Wrana JL. SARA, a FYVE domain protein that recruits Smad2 to the TGFbeta receptor. Cell. 1998; 95: 779–791.CrossrefMedlineGoogle Scholar22 Moustakas A, Souchelnytskyi S, Heldin CH. Smad regulation in TGF-beta signal transduction. J Cell Sci. 2001; 114: 4359–4369.CrossrefMedlineGoogle Scholar23 Wrana J, Pawson T. Signal transduction. Mad about SMADs. Nature. 1997; 388: 28–29.MedlineGoogle Scholar24 Vindevoghel L, Kon A, Lechleider RJ, Uitto J, Roberts AB, Mauviel A. Smad-dependent transcriptional activation of human type VII collagen gene (COL7A1) promoter by transforming growth factor-beta. J Biol Chem. 1998; 273: 13053–13057.CrossrefMedlineGoogle Scholar25 Vindevoghel L, Lechleider RJ, Kon A, de Caestecker MP, Uitto J, Roberts AB, Mauviel A. SMAD3/4-dependent transcriptional activation of the human type VII collagen gene (COL7A1) promoter by transforming growth factor beta. Proc Natl Acad Sci U S A. 1998; 95: 14769–14774.CrossrefMedlineGoogle Scholar26 Hao J, Wang B, Jones SC, Jassal DS, Dixon IM. Interaction between angiotensin II and Smad proteins in fibroblasts in failing heart and in vitro. Am J Physiol Heart Circ Physiol. 2000; 279: H3020–H3030.CrossrefMedlineGoogle Scholar27 Akiyama-Uchida Y, Ashizawa N, Ohtsuru A, Seto S, Tsukazaki T, Kikuchi H, Yamashita S, Yano K. Norepinephrine enhances fibrosis mediated by TGF-beta in cardiac fibroblasts. Hypertension. 2002; 40: 148–154.LinkGoogle Scholar Previous Back to top Next FiguresReferencesRelatedDetailsCited By Legato M and Leghe J (2010) Gender and the Heart Principles of Gender-Specific Medicine, 10.1016/B978-0-12-374271-1.00014-9, (151-161), . Vega J, Keino H and Masli S (2009) Surgical Denervation of Ocular Sympathetic Afferents Decreases Local Transforming Growth Factor-β and Abolishes Immune Privilege, The American Journal of Pathology, 10.2353/ajpath.2009.090264, 175:3, (1218-1225), Online publication date: 1-Sep-2009. October 2004Vol 44, Issue 4 Advertisement Article InformationMetrics https://doi.org/10.1161/01.HYP.0000141484.53649.6fPMID: 15326090 Originally publishedAugust 23, 2004 PDF download Advertisement" @default.
• W2065952992 created "2016-06-24" @default.
• W2065952992 creator A5007467943 @default.
• W2065952992 creator A5037459846 @default.
• W2065952992 date "2004-10-01" @default.
• W2065952992 modified "2023-10-16" @default.
• W2065952992 title "Gender Dependency in the Pathogenesis of Cardiac Hypertrophy" @default.
• W2065952992 cites W1594278877 @default.
• W2065952992 cites W1840163537 @default.
• W2065952992 cites W1918459205 @default.
• W2065952992 cites W1975244118 @default.
• W2065952992 cites W2026623200 @default.
• W2065952992 cites W2030148120 @default.
• W2065952992 cites W2041691782 @default.
• W2065952992 cites W2050744280 @default.
• W2065952992 cites W2051696368 @default.
• W2065952992 cites W2053717115 @default.
• W2065952992 cites W2057161685 @default.
• W2065952992 cites W2063670795 @default.
• W2065952992 cites W2066508034 @default.
• W2065952992 cites W2082429467 @default.
• W2065952992 cites W2087505255 @default.
• W2065952992 cites W2091884993 @default.
• W2065952992 cites W2105050893 @default.
• W2065952992 cites W2114644843 @default.
• W2065952992 cites W2115806873 @default.
• W2065952992 cites W2140883218 @default.
• W2065952992 cites W2317845988 @default.
• W2065952992 doi "https://doi.org/10.1161/01.hyp.0000141484.53649.6f" @default.
• W2065952992 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15326090" @default.
• W2065952992 hasPublicationYear "2004" @default.
• W2065952992 type Work @default.
• W2065952992 sameAs 2065952992 @default.
• W2065952992 citedByCount "2" @default.
• W2065952992 crossrefType "journal-article" @default.
• W2065952992 hasAuthorship W2065952992A5007467943 @default.
• W2065952992 hasAuthorship W2065952992A5037459846 @default.
• W2065952992 hasBestOaLocation W20659529921 @default.
• W2065952992 hasConcept C115903868 @default.
• W2065952992 hasConcept C126322002 @default.
• W2065952992 hasConcept C164705383 @default.
• W2065952992 hasConcept C167414201 @default.
• W2065952992 hasConcept C19768560 @default.
• W2065952992 hasConcept C2780942790 @default.
• W2065952992 hasConcept C3018791406 @default.
• W2065952992 hasConcept C41008148 @default.
• W2065952992 hasConcept C71924100 @default.
• W2065952992 hasConceptScore W2065952992C115903868 @default.
• W2065952992 hasConceptScore W2065952992C126322002 @default.
• W2065952992 hasConceptScore W2065952992C164705383 @default.
• W2065952992 hasConceptScore W2065952992C167414201 @default.
• W2065952992 hasConceptScore W2065952992C19768560 @default.
• W2065952992 hasConceptScore W2065952992C2780942790 @default.
• W2065952992 hasConceptScore W2065952992C3018791406 @default.
• W2065952992 hasConceptScore W2065952992C41008148 @default.
• W2065952992 hasConceptScore W2065952992C71924100 @default.
• W2065952992 hasIssue "4" @default.
• W2065952992 hasLocation W20659529921 @default.
• W2065952992 hasLocation W20659529922 @default.
• W2065952992 hasOpenAccess W2065952992 @default.
• W2065952992 hasPrimaryLocation W20659529921 @default.
• W2065952992 hasRelatedWork W1514902666 @default.
• W2065952992 hasRelatedWork W2031431176 @default.
• W2065952992 hasRelatedWork W2052926718 @default.
• W2065952992 hasRelatedWork W2057908393 @default.
• W2065952992 hasRelatedWork W2125138303 @default.
• W2065952992 hasRelatedWork W2170745559 @default.
• W2065952992 hasRelatedWork W2358470937 @default.
• W2065952992 hasRelatedWork W2416811611 @default.
• W2065952992 hasRelatedWork W2764849705 @default.
• W2065952992 hasRelatedWork W3152327172 @default.
• W2065952992 hasVolume "44" @default.
• W2065952992 isParatext "false" @default.
• W2065952992 isRetracted "false" @default.
• W2065952992 magId "2065952992" @default.
• W2065952992 workType "article" @default.